Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of ezetimibe 10 mg tablet vs Ezetrol 10 mg in healthy Thai volunteers under fasting
TCTR20220629007Phase 1Completed
- Sponsor
- Bio-innova
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ezetimibe (2 arms), sponsored by Bio-innova. Started Jan 2023; status: completed.
02
Drugs
ezetimibe
Beyond the preview
Go deeper on TCTR20220629007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220629007.